Icosavax Inc

NASDAQ ICVX

Data sourced from iex and EODHD
Download Data

Icosavax Inc Income Statement 2019 - 2022

This table shows the Income Statement for Icosavax Inc going from 2019 until 2022. The income statement, also known as the profit and loss statement, is a financial statement that provides a summary of a company's revenues, expenses, and net income over a specific period (such as a quarter or a year). It shows the company's ability to generate revenue, manage expenses, and ultimately determine its profitability.
Income Statement Trend Unit 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Revenue
M 1 8 2 0
Cost of Revenue
M 2 0 18 -
Gross Profit
M -1 8 -16 -
Operating Expenses
M 94 74 3 -
Selling, General, and Administrative Expenses (SG&A)
M 30 35 3 1
Research and Development (R&D) Expenses
M 65 39 18 4
Other Operating Expenses
M -2 0 -18 -
Costs and Expenses
M 93 66 1 -
Operating Income
M -95 -66 -19 -5
Interest Expense
M 3 0 0 0
Non-operating Income/Expense
M 3 -1 0 0
EBT
M -92 -67 -19 -5
Income Tax Provision
M -3 1 0 0
Income after Tax
M -88 -68 -19 -5
Non-Controlling Interest
M 0 0 0 1
Net Income
M -92 -67 -19 -6
Shares (Basic, Weighted)
M - - - -
Shares (Diluted, Weighted)
R 39,725,131.00 17,965,894.00 2,878,163.00 10,240,553.00
EBITDA
M -94 -65 -19 -5
Depreciation and Amortization
M 1 1 0 -
EBIT
M -95 -66 -19 -5
Income from Discontinued Operations
M - - - -
Tax Rate (Effective)
% 3.60 -1.53 -1.76 1.91
Earnings Per Share (EPS), Basic
M - - - -
Earnings Per Share (EPS), Diluted
M 0 0 0 0
Gross Profit Margin
% -216.67 98.95 -993.25 -
Operating Income Margin
% -16,332.99 -844.16 -1,157.80 -
Net Income Margin
% -15,765.98 -858.38 -1,166.71 -
EBITDA Ratio
% -16,185.22 -831.86 -1,157.74 -
EBIT Ratio
% -16,332.99 -844.16 -1,157.80 -
EBT Ratio
% -15,765.98 -858.38 -1,166.71 -

StockViz Staff

September 19, 2024

Any question? Send us an email